HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ishii, K. Search for Related Content PubMed PubMed Citation Articles by Ishii, K.

Advantage of Late Scanning in Brain ¹⁸F-FDG PET

Hyogo Brain and Heart Center Himeji Hyogo, Japan

TO THE EDITOR: I have read with great interest and enthusiasm the recent article by Chen et al. on the rapid scanning protocol for brain ¹⁸F-FDG PET (1). They found that rapid scanning for brain ¹⁸F-FDG PET is nearly equivalent to conventional scanning in the diagnosis of Alzheimer's disease. In their study, rapid scanning was performed later than conventional scanning after ¹⁸F-FDG injection, indicating the advantage of late scanning. Because the receiver-operating characteristic curves indicated that the area under the curve of rapid (late) scanning was slightly larger than that of conventional (early) scanning, their report supports our previous finding that late scanning is superior to early scanning in detecting hypometabolic regions in patients with Alzheimer's disease (2). I am also pleased that their study found regional ¹⁸F-FDG uptake differences between early and late scanning, verifying findings previously reported by my group (3). That is, relative ¹⁸F-FDG uptake in the posterior cingulate and parietal cortices, which are the regions affected in the Alzheimer's diseased brain, are larger at late scanning than at early scanning and ¹⁸F-FDG uptake in the cerebellum is lower at late scanning than at early scanning. We considered that these differences between the 2 sets of scans might have been related to regional differences in rate constants, such as K1, which indicates ¹⁸F-FDG transportation from plasma to tissue, and k3, which indicates phosphorylation of ¹⁸F-FDG (2). I expect this interesting brain physiology to be investigated further by using parametric mapping with compartment models.

References

1. Chen WP, Matsunari I, Noda A, et al. Rapid scanning protocol for brain ¹⁸F-FDG PET: a validation study. J Nucl Med. 2005;46:1633–1641.[Abstract/Free Full Text]
2. Sakamoto S, Ishii K, Hosaka K, Mori T, Sasaki M, Mori E. Detectability of hypometabolic regions in mild Alzheimer disease: function of time after the injection of 2-[fluorine 18]-fluoro-2-deoxy-D-glucose. AJNR. 2005;26:843–847.[Abstract/Free Full Text]
3. Ishii K, Sakamoto S, Hosaka K, Mori T, Sasaki M. Variation in FDG uptakes in different regions in normal human brain as a function of the time (30 and 60 minutes) after injection of FDG. Ann Nucl Med. 2002;16:299–301.[Medline]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ishii, K. Search for Related Content PubMed PubMed Citation Articles by Ishii, K.